CN101985634A - GFP membrane type expression vector and method for sorting vector-transfected positive cells - Google Patents
GFP membrane type expression vector and method for sorting vector-transfected positive cells Download PDFInfo
- Publication number
- CN101985634A CN101985634A CN 201010531802 CN201010531802A CN101985634A CN 101985634 A CN101985634 A CN 101985634A CN 201010531802 CN201010531802 CN 201010531802 CN 201010531802 A CN201010531802 A CN 201010531802A CN 101985634 A CN101985634 A CN 101985634A
- Authority
- CN
- China
- Prior art keywords
- gfp
- cell
- sequence
- membranous type
- positive cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a green fluorescent protein (GFP) membrane type expression vector and a method for sorting vector-transfected positive cells. The GFP membrane type expression vector comprises a multiple-cloning site, wherein a ribosome entry site and a GFP-encoded sequence are connected behind the multiple-cloning site in turn to form a transcription bicistron of the multiple-cloning site and the GFP; a signal peptide-encoded sequence is inserted between the ribosome entry site and the GFP-encoded sequence; and a hydrophobic transmembrane region-encoded sequence is added in front of a termination codon of the GFP-encoded sequence. After the GFP membrane type expression vector cloned into a target gene is successfully transfected into the cell, a unique sorting label, namely membrane type GFP, is formed on the surface of the cell, and the sorting label is not formed if the transfection is not successful. By sorting magnetic bead-combined positive cells by using a magnetic field, the sorting step is simplified, so that the positive cells can be rapidly and effectively enriched, and the method is a technical means for efficiently sorting the transfected positive cells.
Description
Technical field
The invention belongs to biological technical field, relate to the screening of external source destination gene expression positive cell, be particularly related to the carrier for expression of eukaryon of a kind of GFP (green fluorescent protein) membranous type expression as sorting indicia, and the method for carrying out the transfectional cell sorting of utilizing this carrier.
Background technology
In modern biotechnology, utilize plasmid or virus vector that foreign gene is imported host cell, to make exogenous gene high-efficient expressed be a very important technology thereby increase in host cell, transcribe, translate; No matter be the original biological behaviour of importing change host cell by foreign gene, the foreign protein that still utilizes host cell expression to have biologic activity all has very to be used widely.But this technology has the bottleneck of a key, is exactly the not high problem of transfection efficiency.
Generally speaking, different with clone and transfection reagent, transfection efficiency also has nothing in common with each other, but totally all on the low side.Because transfection efficiency is low, behind the goal gene transfection host cell, the wild-type host cell of expression alien gene does not still account for major part; Heterogeneous cell colony has like this influenced the science of experimental result greatly for the specific cells of needs research.Thereby, after the gene transfection operation is finished, how from the cell mass of enormous amount, to detect and sub-elect to the few goal gene transfection positive cells of number, improve transfection efficiency, just become a key setting up the eukaryotic cell expression system.
The positive cell of screening transfection at present method commonly used is to add one section drug resistance gene in carrier for expression of eukaryon, screen by in cell culture system, adding corresponding cytotoxic drug generation selective pressure, for example the neomycin resistance gene of widespread usage (neor).Its principle is that thereby aminoglycoside antibiotics Xin Meisu and analogue G418 thereof can be by suppressing ribosomal function and the proteinic synthetic wild-type cell that kills.The neo genes encoding aminoglycoside phosphotransferase that carries on the carrier for expression of eukaryon, its protein product can decompose Xin Meisu and G418, can make transfection the positive cell of purpose carrier obtain resistance and can in containing the selective medium of G418, grow.Principle similarly also has the selection of Zeocin resistance, the selection of Hygromycine resistance, the selection of Puromycine resistance etc. therewith.
Though above-mentioned drug resistance gene triage techniques can effectively be removed the wild-type cell that does not import plasmid, enlarged gene transfection The Application of Technology scope, but still had weak point.Particularly, for transient transfection, although the expression of the expression of resistant gene and goal gene is synchronous, but in the short period (a couple of days) of transient expression, Cytotoxic microbiotic can't effectively kill wild-type cell, and the heterogeneous cell mass after the transfection still can not satisfy most of experimental requirements; Carry out resistance screening to obtain often can the long-term expression goal gene stable cell line, at this moment because the resistant gene of plasmid and goal gene belong to two transcripts under the different promoters control respectively, its process that is incorporated into the host cell gene group is at random, thereby two genes not necessarily are incorporated into genome simultaneously, even be incorporated in the genome of same cell, because the position influence that gene inserts, two genes might not be expressed simultaneously, when therefore transfectional cell being screened by the method for resistant gene selective pressure, the final transfectional cell that is obtained is the cell of resistant gene stably express in fact, and the destination gene expression level that the investigator was concerned about becomes randomized number.And, along with the prolongation of incubation time and the increase of passage number of times, the cell load of expressing resistant gene and goal gene is simultaneously more only expressed the cell load of resistant gene and is wanted big, the ratio that accounts in cell mass will further descend (except goal gene can promote indivedual Special Circumstances of cell proliferation).This scheme efficient not only consuming time but also low will sub-elect the time that the cell strain of having expressed goal gene need expend one even some months usually, and the final cell strain that obtains probably remains heterogeneous cell mass.
So, in order to solve the problem of the host cell that how to obtain the high purity expression alien gene, improve the transfection efficiency except developing new transfection reagent, the increasing technology positive cell of goal gene that has been applied to how sorting transfection is arranged in recent years.Some characteristic of utilizing transfectional cell to obtain such as dyeing of transfectional cell expression specificity or fluorescin, is carried out sorting by flow cytometer.
Green fluorescent protein (GFP) derives from Victoria's multitube luminescent jellyfish, and the mutant GFP albumen after genetic engineering modified can send green fluorescence under the 488nm laser radiation, and its emission peak is in the green area of visible spectrum at 509nm.GFP generally is positioned at two places as a kind of selection markers in existing commercial carrier for expression of eukaryon, and the one, (MCS) locates in multiple clone site, and goal gene forms amalgamation and expression with GFP after inserting MCS, and promptly ripe proteic N end or C end have the GFP label; Second kind of situation is after GFP is positioned at ribosome entry site(RES) (IRES), to be transcribed into bicistronic mRNA, the free tenuigenin inside that is expressed in of GFP.Generally speaking, GFP can sub-elect transfection positive cells group by flow cytometry as selection markers, but common flow cytometer can not carry out the branch selection operation, airflow classification depends on expensive large-scale professional plant and instrument (as the FACS Aria type of BD company), higher and the pair cell of required expense has certain damage, it is applied be restricted.
In recent years, utilize the specific protein molecule of cell surface, come the method for certain cell type of sorting that more and more widely application is arranged in life science and clinical practice by the antigen and antibody specific association reaction.For example people's such as the Pei Xue of military medicine research institute great waves invention " contains structure and application thereof that the CD34 marker gene is used for the carrier of transfectional cell sorting " (publication number CN1712535A).Utilize the CD34 molecule as the screening sign, can sub-elect the transfection positive cell of expressing goal gene and CD34 molecule simultaneously, but still there is the drawback that influences its widespread use in this scheme: the CD34 molecule is the native protein of mammalian cell, be expressed in the various kinds of cell surface, as hematopoietic stem, as the label protein molecule, its range of application is just limited to CD34.The CD34 molecule can interact with CD62L molecule generation specificity, and transfectional cell ectopic expression CD34 can cause interference to the part cytologic experiment.
Summary of the invention
The technical problem that the present invention solves is to provide a kind of carrier of GFP membranous type expression, and the sorting method of the positive cell of this carrier of transfection, the defective that overcome that above-mentioned transfection efficiency is low, there is limitation in mdr cell false positive height, sorting technology, simplify traditional transfectional cell screening process, improve the efficiency of separation of transfectional cell.
The present invention is achieved through the following technical solutions:
The carrier that a kind of GFP membranous type is expressed comprises multiple clone site, is connected with the sequence of ribosome entry site(RES) and encoding green fluorescent protein after the multiple clone site in turn, constitutes the bicistronic mRNA of transcribing of multiple clone site and green fluorescent protein; Between the sequence of ribosome entry site(RES) and encoding green fluorescent protein, insert the sequence of coded signal peptide, before the sequence terminator codon of encoding green fluorescent protein, add the sequence that the coding hydrophobicity is striden the film district.
The sequence of described signal peptide is shown in SEQ.ID.NO.1; Described hydrophobicity is striden the film region sequence shown in SEQ.ID.NO.2.
The sequence of described coded signal peptide is shown in SEQ.ID.NO.3; Described coding hydrophobicity is striden the sequence in film district shown in SEQ.ID.NO.4.
The sorting method of the positive transfectional cell behind the GFP membranous type expression vector transfectional cell,, may further comprise the steps:
1) inserts the external source goal gene in the multiple clone site of GFP membranous type expression vector, constitute the bicistronic mRNA of transcribing of external source goal gene and green fluorescent protein; Behind GFP membranous type expression vector transfection host cell, collect cell to be separated and make single-cell suspension liquid then;
2) will resist GFP monoclonal antibody and two diamagnetic pearls to mix, and make anti-GFP monoclonal antibody be attached to the surface of two diamagnetic pearls;
3) add the two diamagnetic pearls that combine anti-GFP monoclonal antibody at the single-cell suspension liquid of making, fully mixing makes the two diamagnetic pearls that combine anti-GFP monoclonal antibody combine with the positive cells transfected that the GFP membranous type is expressed;
4) under the action of a magnetic field, the positive cells transfected and the cellular segregation that does not combine two diamagnetic pearls of two diamagnetic pearls will be combined; Collection combines the positive cells transfected of two diamagnetic pearls, and magnetic bead is separated with positive cells transfected, obtains the positive cells transfected of purifying.
Described two diamagnetic pearls are that magnetic bead is connected with the antibody that can discern anti-GFP monoclonal antibody by connecting DNA.
Described anti-GFP monoclonal antibody is the mouse endogenous antibody, and two diamagnetic pearls are that magnetic bead is connected with the monoclonal antibody of the anti-mouse of people by connecting DNA.
Compared with prior art, the present invention has following beneficial technical effects:
1, the carrier of GFP membranous type expression provided by the invention, under the guiding of signal peptide, pass cytolemma behind the egfp expression, and stride in hydrophobicity under the effect in film district and be bonded to surface of cell membrane, become the new screening label of positive transfectional cell---membranous type GFP (mGFP); And simultaneously because goal gene will be transcribed bicistronic mRNA with green fluorescence protein gene formation after inserting multiple clone site, realize the coexpression of goal gene and membranous type GFP, membranous type GFP just becomes the surface molecular mark of the positive transfectional cell that goal gene expressed like this.Also promptly, be cloned into after the GFP membranous type expression vector transfectional cell success of goal gene, can form unique screening label---membranous type GFP, do not have then can not forming of transfection success at cell surface.
And by specificity combination, immunomagnetic beads absorption carrying out sorting cells at the GFP monoclonal antibody, and because the specificity of expressing and the specificity of antigen-antibody recognition reaction, can guarantee the reconstitution cell goal gene that screened and the consistence of GFP screening label positive expression like this; Especially membranous type GFP is the antigen-antibody identification of cell surface in screening as the cell surface molecule mark, can simplify the screening step, realizes the fast enriching of positive cell.
2, Chang Yong eukaryotic cell does not have endogenous GFP gene, unless the external source transfection, otherwise do not express membranous type GFP molecule, membranous type GFP can not cause false positive results as evaluation or selective marker; And, do not exist on the eukaryotic cell can with GFP high-affinity bonded native ligand protein molecular, can not influence the biological behaviour of expressing the GFP cell, reduced the interference of experimental implementation to the result.
3, the present invention utilizes gene engineering method to make GFP be fixed in surface of cell membrane by striding the film region sequence, this sequence is that 29 hydrophobic amino acids constitute, the cytolemma lipid is double-deck to be fixed in the cytolemma outside surface with the GFP molecule thereby insert, do not contain the cytoplasmic region part, influence the biological behaviour of cell so can not transduce outer signals.
4, the external source goal gene inserts behind the MCS to transcribe with mGFP becomes a bicistronic mRNA, the aminoterminal of green fluorescent protein is connected with signal peptide sequence, what carboxyl terminal was connected with hydrophobic amino acid strides the film region sequence, GFP albumen can be on film, expressed behind this expression vector of cell transfecting, the external source goal gene can also be expressed simultaneously.Under same promotor, express the open reading frame of two fragment genes respectively, make the expression of the new sign of the expression of external source goal gene and cell surface have good dependency, and this dependency has guaranteed that the cell of the expression film sign mGFP that sub-elects also is simultaneously the cell of expressing goal gene.
5, the cell sorting method of GFP-transfected membranous type expression vector provided by the invention, by the GFP antigen and antibody specific in conjunction with the absorption of, immunomagnetic beads, magnetic field sorting flow process in conjunction with the positive cell of magnetic bead, simplified the screening step, can be fast effective enrichment positive cell, and the defective of having avoided microbiotic to screen for a long time, can also improve the screening ratio of transfection positive cell, be a kind of technique means that can efficiently sub-elect the transfection positive cell.
Generally speaking, the transfection efficiency of common mammalian cell promptly has about 20% cell expressing goal gene in the cell mass after the transfection about 20%; And the sorting by present technique, the enrichment positive cell rises to more than 95% the positive cell ratio.
Description of drawings
Fig. 1 is the plasmid map of the membranous type GFP expression vector pIRES-mGFP that makes up of the present invention;
Fig. 2 is the schematic flow sheet of the cell sorting method of transfection membranous type GFP expression vector.
Embodiment
The present invention has made up the carrier that a kind of GFP membranous type is expressed, after multiple clone site, be connected with the sequence of ribosome entry site(RES) and encoding green fluorescent protein in turn, constitute the bicistronic mRNA of transcribing of multiple clone site and green fluorescent protein, make the goal gene coexpression of green fluorescent protein and insertion multiple clone site; And before the sequence terminator codon of encoding green fluorescent protein, add the sequence that the coding hydrophobicity is striden the film district; (leading sequence, LS) shown in SEQ.ID.NO.1, (transmembrane sequence, the sequence of 29 hydrophobic amino acids TM) is shown in SEQ.ID.NO.2 as striding the film district for the signal peptide sequence of 20 hydrophobic amino acids.
Make the green fluorescent protein with the goal gene coexpression under the guiding of signal peptide, pass cytolemma like this, and stride in hydrophobicity under the effect in film district and be bonded to surface of cell membrane, become the new screening label of positive transfectional cell---membranous type GFP.
The cell sorting method of GFP-transfected membranous type expression vector provided by the invention has not only been simplified traditional loaded down with trivial details time-consuming procedure again of transfectional cell screening, and has improved the efficiency of separation of transfectional cell, will be widely used at life science.
A kind of membranous type expressing green fluorescent protein is as the carrier for expression of eukaryon of sorting indicia, the sequence of encoding green fluorescent protein is positioned at after the ribosome entry site(RES), be built into the bicistronic mRNA of transcribing of multiple clone site and green fluorescent protein, between the sequence of ribosome entry site(RES) and encoding green fluorescent protein, insert
The carrier that the GFP membranous type is expressed elaborates below:
At first, select green fluorescent protein (GFP) as the cell surface marker molecule.GFP has the advantage of following several respects as the surface of cell membrane sign: 1.GFP pair cell toxicity is extremely low, and instantaneous and stably express does not all influence the survival and the biological behaviour of cell, has been widely used in many research fields of life science at present; 2.GFP three-dimensional structure is that typical β is barrel-shaped, comprises βZhe Die and α spiral, and fluorophor is included in wherein, has good anti-cancellation structure, can tolerate the operation of long period; 3.GFP send bright green fluorescence after being stimulated, transfectional cell can pass through the detection of multiple instrument qualitative, quantitatives such as fluorescent microscope, board-like fluorescent quantitation instrument or flow cytometer; 4. Chang Yong eukaryotic cell does not have endogenous GFP gene, unless the external source transfection, otherwise do not express the GFP molecule, can not cause false positive results as evaluation or selective marker; 5. on eukaryotic cell, do not exist can with GFP high-affinity bonded native ligand protein molecular, can not influence the biological behaviour of expressing the GFP cell, reduced the interference of experimental implementation to the result.
Secondly, by between IRES and GFP, inserting signal peptide sequence (leading sequence, LS), before the GFP terminator codon, add and stride film district (transmembrane sequence, TM) sequence, pass and be anchored to the cytolemma outer surface after this genetically engineered operation makes GFP express, become the new screening label-membranous type GFP of transfectional cell, be called mGFP.The TM sequence is only inserted cytolemma lipid bilayer, does not contain the cytoplasmic region part, can the transfer cell external signal and influence the biological behaviour of cell.
Become a bicistronic mRNA because the effect of IRES sequence, external source goal gene insert behind the MCS to transcribe with mGFP, under same promotor, express the open reading frame (ORF) of two fragment genes respectively.Therefore, host cell if express the GFP label protein on the film, then is bound to express the external source goal gene after operating through transfection.The reconstruction of such genetically engineered can be so that the expression of the new sign of the expression of external source goal gene and cell surface has good dependency, and this dependency has guaranteed that the cell of the expression film sign mGFP that sub-elects also is simultaneously the cell of expressing goal gene.
With the be configured to embodiment of PIRES2-AcGFP1 carrier, the Construction of eukaryotic process of green fluorescent protein as sorting indicia is described below to as shown in Figure 1 PIRES2-mGFP carrier.
The pIRES2-AcGFP carrier is to the construction step of pIRES2-mGFP carrier:
1. the chemical synthesis coding signal peptide with stride the Nucleotide of film region sequence, 5 ' end adds the BstXI site, 3 ' end adds the XbaI site, design adds BamHI in the middle of both, KpnI, EcoRI, four kinds of restriction enzyme sites of HindIII (promptly hold 3 ' end to be from 5 ': BstXI-LS-(BamHI, KpnI, EcoRI, HindIII)-TM-XbaI), sequence is inserted the pUC57-T-simple carrier in T-A clone mode, called after pUC-LSTM, wherein the nucleotide sequence of coded signal peptide is shown in SEQ.ID.NO.3, and coding is striden the nucleotide sequence of film region sequence shown in SEQ.ID.NO.4.
2. be template with pIRES2-AcGFP carrier (Clontech company, article No. 632435), the design primer amplification goes out GFP, and adds BamHI and HindIII site at GFP fragment two ends, is connected into above-mentioned pUC-LSTM carrier after enzyme is cut, called after pUC-LGT;
3. from above-mentioned pUC-LGT carrier, cut out LS-GFP-TM with BstXI and XbaI enzyme, and enzyme is cut pIRES-AcGFP, difference glue recovery fragment and carrier;
4. connect the pIRES-AcGFP carrier of LS-GFP-TM and excision GFP, successfully construct carrier pIRES2-mGFP.
By the operation of said gene engineering, original pIRES2-AcGFP carrier changes to constitute expresses the proteic pIRES2-mGFP carrier of membranous type GFP.
Referring to Fig. 2, the cell sorting method of GFP-transfected membranous type expression vector may further comprise the steps:
1), the goal gene nucleic acid fragment of needs research is inserted into the multiple clone site place of above-mentioned carrier, the GFP membranous type expression vector of construction expression external source goal gene by gene engineering method; Utilize liposome mediated-method or methods such as calcium phosphate mediated method or electroporation with the expression vector transfection host cell that successfully constructs, collect transfectional cell after 24～48 hours, make single-cell suspension liquid;
2) will resist GFP monoclonal antibody and two diamagnetic pearls to mix, and make anti-GFP monoclonal antibody be attached to the surface of two diamagnetic pearls;
3) add the two diamagnetic pearls that combine anti-GFP monoclonal antibody at the single-cell suspension liquid of making, fully mixing makes two diamagnetic pearls combine with the membranous type GFP of positive cells transfected surface expression;
4) utilize external magnetic field to sub-elect the transfection positive cell of expressing membranous type GFP, utilize damping fluid (Releasing Buffer) effect of shearing again, the transfection positive cell of expressing membranous type GFP is separated with immunomagnetic beads, thereby obtain the transfection positive cell of sorting purifying.
Below this method is elaborated.Main commercialization reagent and equipment: anti-mouse two diamagnetic pearl: CELLection
TMPan Mouse IgG Kit test kit (Dynal company, article No. 115-31D); Magnet stand is used to provide external magnetic field, adopts Dynal MPC-S type magnet stand (Dynal company, article No. 120-20D); RPMI1640 cell culture medium (Hyclone company); New-born calf serum (folium ilicis chinensis company); Bovine serum albumin BSA (Sigma company); Vertical mixed instrument (the Ningbo Xin Zhi HS-3 of company type).
White row reagent preparation: PBS damping fluid: 0.15mol/L, pH 7.4; Buffer1: contain mass/volume than being the PBS damping fluid of 0.1%BSA; Buffer2: the RPMI1640 cell culture medium that contains volume ratio and be 1% new-born calf serum; Specificity is in conjunction with the mouse monoclonal antibody FMU-GFP.5 of GFP.
1, the collection of transfectional cell
Utilize liposome mediated-method or methods such as calcium phosphate mediated method or electroporation with the expression vector transfection host cell that successfully constructs, collect transfectional cell after 24～48 hours, make individual cells suspension.
If host cell is a suspended culture cell, 1200rpm then, 5min is centrifugal, abandons supernatant, with the fresh culture re-suspended cell precipitation of proper volume; If the cell of adherent culture, need to exhaust substratum, digest with 0.25% pancreatin-0.02%EDTA-PBS damping fluid, make cell become suspended state, 1200rpm then, 5min is centrifugal, abandons supernatant, with the fresh culture re-suspended cell precipitation of proper volume, make individual cells suspension.
2) combining of the monoclonal antibody of anti-GFP and two diamagnetic pearls:
Get 100 μ l, two diamagnetic pearl suspensions and (contain 4 * 10
7Individual magnetic bead), behind the adding 1ml Buffer1 thorough washing, on magnet stand, leaves standstill 1min, inhale and abandon supernatant, add 1ml Buffer1 mixing; Add 2 μ g monoclonal antibody FMU-GFP.5 again, place on the vertical mixing instrument 4 ℃ to put upside down mixing 30～60min; On magnet stand, leave standstill 1min, inhale and abandon supernatant, again with Buffer1 washing 2 times.
The monoclonal antibody of anti-GFP can be commercialization reagent or white row preparation, and commercialization reagent: the how tame biotech company that comprises Sigma all has commercial monoclonal antibody to provide.
Embodiments of the invention are selected the FMU-GFP.5 monoclonal antibody, the preparation method of this monoclonal antibody: what immunogen adopted is prokaryotic expression recombinant GFP albumen, immunity Balb/c mouse, extracting spleen cell and Sp2/0 myeloma cell are merged, through the indirect elisa method screening, the limiting dilution assay cloning obtains can be in conjunction with the proteic monoclonal antibody of GFP.Concrete grammar is seen open source literature: Ran Zhuang, Yuan Zhang, Rui Zhang, Chaojun Song, Kun Yang, Angang Yang, Boquan Jin.Purification of GFP fusion proteins with high purity and yield by monoclonal antibody-coupled affinity column chromatography.Protein Expression and Purification.2008; 59 (1): 138-143, the researcher in this field can ask for the FMU-GFP.5 monoclonal antibody from the disclosed laboratory of above-mentioned document easily.The required anti-GFP specific monoclonal antibody of this step also can buy obtain from biotech company, for example green skies biotech company (product article No.: AG281).
3) add the two diamagnetic pearls that are combined with anti-GFP monoclonal antibody
The monoclonal antibody of anti-GFP with join in the individual cells suspension of making after two diamagnetic pearls combine, in the liquid phase buffering system, immobilised specificity in conjunction with the anti-monoclonal antibody of the GFP of GFP can high-affinity in conjunction with the positive transfectional cell of expressing membranous type GFP.
4) utilize the external magnetic field sorting to express the cell of certain films surface marker
1, adjusting transfectional cell density with Buffer1 is 1 * 10
7, get the 1ml cell suspension and be combined with the magnetic bead mixing of monoclonal antibody, put on the vertical mixing instrument 4 ℃ and put upside down mixing 20min; On magnet stand, leave standstill 2min then, inhale and to abandon supernatant to remove not negative cells in conjunction with magnetic bead; Add 1ml Buffer1 mixing, on magnet stand, leave standstill 1min, inhale and abandon supernatant, repeat 3 times washed cell, exhaust supernatant for the last time.
2, add 200 μ l in the Buffer2 of 37 ℃ of preheatings re-suspended cell, adding 4 μ l DNase I solution digestion connects and is connected DNA (the connection antibody that has on the commercialization reagent immunomagnetic beads is with the DNA chain of magnetic bead or be connected DNA) between immunomagnetic beads and the anti-mouse monoclonal antibody of people, put upside down mixing 15min under the room temperature, firmly blow and beat suspension 5～10 times so that immunomagnetic beads and positive cell dissociate with the pipettor suction nozzle.On magnet stand, leave standstill 2min, inhale and abandon supernatant, repeat 3 times washed cell.The cell that obtains is highly purified transfection positive cell.
The structure of embodiment 1:pIRES2-mGFP-CD226 carrier
With CD226 gene insertion pIRES2-mGFP carrier as shown in Figure 1.The CD226 gene source is in the pEF-BOS-CD226 carrier, open reading frame ORF gene order according to pIRES2-mGFP multiple clone site restriction enzyme site and CD226, the design primer is introduced XhoI and BamHI restriction enzyme site, and primer sequence and high-fidelity PCR reaction conditions are as follows:
P1:gcctcgagat ggattatcct actttact 28 (underscore is the XhoI site)
P2:ggggatcctt aaactctagt ctttggtct 29 (underscore is the BamHI site)
100 μ l reaction systems comprise: pEF-BOS-CD226 plasmid 0.1 μ l, each 5ul of primer P1 and P2 (10 μ M), dNTP (2.5mM) 8ul, high-fidelity DNA polymerase PrimerStar (TaKaRa company) 0.5 μ l, 5 * PCR Buffer 20ul, distilled water 81.4 μ l.Reaction conditions: 94 ℃ of pre-sex change 5min; 94 ℃ of sex change 30sec; 59 ℃ of annealing 45sec, 72 ℃ are extended 90sec; 35 circulations; 72 ℃ are extended 10min.
The PCR product adopts XhoI and BamHI to carry out double digestion after the fast purifying test kit is purified, and carries out fast purifying once more; Get pIRES2-mGFP simultaneously and carry out double digestion, use the fast purifying test kit to purify with XhoI and BamHI.PCR product after enzyme is cut is connected under the effect of T4DNA ligase enzyme with linear carrier, and condition is: 16 ℃, and reaction overnight.Transformed into escherichia coli E.coli, shop Kan resistance LB flat board, the picking clone identifies after 37 ℃ of incubated overnight, obtains plasmid pIRES2-mGFP-CD226.
Embodiment 2:pIRES2-mGFP-CD226 carrier transfection CHO cell
In the 75cm2 culturing bottle, cultivate Chinese hamster ovary celI with the DMEM cell culture medium that contains 10% new-born calf serum, converge rate to 80%, exhaust substratum, digest with 0.25% pancreatin-0.02%EDTA-PBS damping fluid, make cell become suspended state, cell is changed in the 15ml centrifuge tube over to 1200rpm, 5min is centrifugal, abandon supernatant, with the electroporation damping fluid re-suspended cell precipitation of proper volume, 1200rpm then, the centrifugal supernatant of abandoning of 5min, washed cell 2 times is made individual cells suspension, counting cells, cell is suspended in the electroporation damping fluid again, and adjusting final concentration of cells is 1 * 10
7Individual cell/ml.Get the 1ml cell suspension and put into electric revolving cup, add 50 μ g recombinant vectors pIRES2-mGFP-CD226, ice bath 10min, the electroporation transfection CHO cell, the electroporation apparatus parameter is provided with: voltage 300V, electric weight 250 μ F.With an amount of substratum diluting cells, the G418 selectivity is cultivated 48h, presses the preceding method harvested cell after the transfection.
Embodiment 3: the immunological magnetic bead sorting of transfection positive cell
Get 100ul two diamagnetic pearl suspensions and (contain 4 * 10
7Individual magnetic bead), add 1ml Buffer1 thorough washing, on magnet stand, leave standstill 1min, inhale and abandon supernatant, add 1ml Buffer1 mixing, add 2 μ g monoclonal antibody FMU-GFP.5, place on the vertical mixing instrument and put upside down mixing, 4 ℃, 30～60min.On magnet stand, leave standstill 1min, inhale and abandon supernatant, again with Buffer1 washing 2 times;
Chinese hamster ovary celI is conventional behind the electroporation transfection cultivated 48 hours, and foreign gene is expressed.Exhaust substratum, digest, make cell become suspended state with 0.25% pancreatin-0.02%EDTA-PBS damping fluid, cell is changed in the 15ml centrifuge tube, 1200rpm, 5min is centrifugal, abandon supernatant, use proper volume Buffer1 washed cell 2 times, and the adjustment cell density is 1 * 10
7Get 1ml cell suspension and the magnetic bead mixing that is combined with monoclonal antibody, put on the vertical mixing instrument and put upside down mixing, 4 ℃, 20min; On magnet stand, leave standstill 2min then, inhale and to abandon supernatant to remove not negative cells in conjunction with magnetic bead.Add 1ml Buffer1 mixing, on magnet stand, leave standstill 1min, inhale and abandon supernatant, repeat 3 times washed cell, exhaust supernatant for the last time.
Add 200ul in the Buffer2 of 37 ℃ of preheatings re-suspended cell, 8 add the digestion of 4ul DNase I solution connects DNA, to cut off being connected of magnetic bead and positive cell, put upside down mixing 15min under the room temperature, firmly blow and beat suspension 5-10 time so that cell separates with magnetic bead with the pipettor suction nozzle.On magnet stand, leave standstill 2min, inhale and abandon supernatant, repeat 3 times washed cell.The cell that obtains is highly purified transfection positive cell, continues to cultivate after can directly carrying out next step analysis or adding substratum.
Claims (6)
1. the carrier that the GFP membranous type is expressed is characterized in that, comprises multiple clone site, is connected with the sequence of ribosome entry site(RES) and encoding green fluorescent protein after the multiple clone site in turn, constitutes the bicistronic mRNA of transcribing of multiple clone site and green fluorescent protein; Between the sequence of ribosome entry site(RES) and encoding green fluorescent protein, insert the sequence of coded signal peptide, before the sequence terminator codon of encoding green fluorescent protein, add the sequence that the coding hydrophobicity is striden the film district.
2. the carrier that GFP membranous type as claimed in claim 1 is expressed is characterized in that the sequence of described signal peptide is shown in SEQ.ID.NO.1; Described hydrophobicity is striden the film region sequence shown in SEQ.ID.NO.2.
3. the carrier that GFP membranous type as claimed in claim 1 is expressed is characterized in that the sequence of described coded signal peptide is shown in SEQ.ID.NO.3; Described coding hydrophobicity is striden the sequence in film district shown in SEQ.ID.NO.4.
4. the sorting method of the positive transfectional cell behind the described GFP membranous type of the claim 1 expression vector transfectional cell is characterized in that, may further comprise the steps:
1) inserts the external source goal gene in the multiple clone site of GFP membranous type expression vector, constitute the bicistronic mRNA of transcribing of external source goal gene and green fluorescent protein; Behind GFP membranous type expression vector transfection host cell, collect cell to be separated and make single-cell suspension liquid then;
2) will resist GFP monoclonal antibody and two diamagnetic pearls to mix, and make anti-GFP monoclonal antibody be attached to the surface of two diamagnetic pearls;
3) add the two diamagnetic pearls that combine anti-GFP monoclonal antibody at the single-cell suspension liquid of making, fully mixing makes the two diamagnetic pearls that combine anti-GFP monoclonal antibody combine with the positive cells transfected that the GFP membranous type is expressed;
4) under the action of a magnetic field, the positive cells transfected and the cellular segregation that does not combine two diamagnetic pearls of two diamagnetic pearls will be combined; Collection combines the positive cells transfected of two diamagnetic pearls, and magnetic bead is separated with positive cells transfected, obtains the positive cells transfected of purifying.
5. the sorting method of the positive transfectional cell behind the GFP membranous type expression vector transfectional cell as claimed in claim 4 is characterized in that, described two diamagnetic pearls are that magnetic bead is connected with the antibody that can discern anti-GFP monoclonal antibody by connecting DNA.
6. the sorting method of the positive transfectional cell behind the GFP membranous type expression vector transfectional cell as claimed in claim 4, it is characterized in that, described anti-GFP monoclonal antibody is the mouse endogenous antibody, and two diamagnetic pearls are that magnetic bead is connected with the monoclonal antibody of the anti-mouse of people by connecting DNA.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105318027A CN101985634B (en) | 2010-11-04 | 2010-11-04 | GFP membrane type expression vector and method for sorting vector-transfected positive cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105318027A CN101985634B (en) | 2010-11-04 | 2010-11-04 | GFP membrane type expression vector and method for sorting vector-transfected positive cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101985634A true CN101985634A (en) | 2011-03-16 |
| CN101985634B CN101985634B (en) | 2012-06-13 |
Family
ID=43710034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105318027A Expired - Fee Related CN101985634B (en) | 2010-11-04 | 2010-11-04 | GFP membrane type expression vector and method for sorting vector-transfected positive cells |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101985634B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103388001A (en) * | 2013-07-16 | 2013-11-13 | 中国人民解放军第四军医大学 | A thrombin cleavage site-containing GST membrane expression vector and a method for sorting transfected positive cells |
| CN106456744A (en) * | 2014-04-01 | 2017-02-22 | 鲁比厄斯治疗法股份有限公司 | Methods and compositions for immunomodulation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6316181B1 (en) * | 1998-04-24 | 2001-11-13 | Virginia Commonwealth University | Establishment of cell lines with persistent expression of a green fluorescent protein (GFP) using a pIRES/EGFP DNA vector construct |
| CN101463362A (en) * | 2009-01-15 | 2009-06-24 | 中国农业大学 | Expression vector for fusion expression of green fluorescent protein, construction method and use thereof |
-
2010
- 2010-11-04 CN CN2010105318027A patent/CN101985634B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6316181B1 (en) * | 1998-04-24 | 2001-11-13 | Virginia Commonwealth University | Establishment of cell lines with persistent expression of a green fluorescent protein (GFP) using a pIRES/EGFP DNA vector construct |
| CN101463362A (en) * | 2009-01-15 | 2009-06-24 | 中国农业大学 | Expression vector for fusion expression of green fluorescent protein, construction method and use thereof |
Non-Patent Citations (2)
| Title |
|---|
| 《PROTEIN EXPRESSION AND PURIFICATION》 20081231 RAN ZHUANG, ET AL Purification of GFP fusion proteins with high purity and yield 138-143 1-6 第59卷, 2 * |
| 《生物化学与生物物理进展》 20051231 曲笑霞，等 一个用于转染细胞分选的双顺反子载体的构建及其应用 889－894 1－6 第32卷, 第9期 2 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103388001A (en) * | 2013-07-16 | 2013-11-13 | 中国人民解放军第四军医大学 | A thrombin cleavage site-containing GST membrane expression vector and a method for sorting transfected positive cells |
| CN103388001B (en) * | 2013-07-16 | 2016-01-20 | 中国人民解放军第四军医大学 | A kind of method containing thrombin cleavage site GST membranous type expression vector and transfection positive cell |
| CN106456744A (en) * | 2014-04-01 | 2017-02-22 | 鲁比厄斯治疗法股份有限公司 | Methods and compositions for immunomodulation |
| US11576934B2 (en) | 2014-04-01 | 2023-02-14 | Rubius Therapeutics, Inc. | Methods and compositions for immunomodulation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101985634B (en) | 2012-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102197136B (en) | Cell surface display by the polypeptide isoforms of termination codon liaison | |
| CN107012121B (en) | Construction of Stable cell lines carrying orthogonal tRNA/aminoacyltRNA synthetases | |
| CN108368505A (en) | Improved FLARE (flow cytometry weakens report protein expression) technology is sorted for rapid batch | |
| EP2700713B1 (en) | Screening and enrichment system for protein expression in eukaryotic cells using a tricistronic expression cassette | |
| CN116554305A (en) | Recombinant humanized III-type collagen, preparation method and application thereof | |
| US10329594B1 (en) | Cell lines for high level production of protein-based pharmaceuticals | |
| JP6159256B2 (en) | Membrane-bound reporter molecules and their use in cell sorting | |
| CN101985634B (en) | GFP membrane type expression vector and method for sorting vector-transfected positive cells | |
| CN104087612B (en) | Method for fast screening mammal cell strain having high exogenous protein expression level | |
| Guo et al. | Status and developmental trends in recombinant collagen preparation technology | |
| CN108753827A (en) | A kind of targeting excretion body carries out carrier and its construction method and application that gene carries medicine | |
| CN101988049B (en) | Genetically modified cell of coexpression mouse membranous type interleukin 15 and retinoic acid early transcript 1 epsilon (Rae-1 epsilon) and preparation method thereof | |
| CN102392047B (en) | Bicistronic mRNA (messenger ribonucleic acid) expression vector suitable for cells of mammals and application thereof | |
| CN103388001B (en) | A kind of method containing thrombin cleavage site GST membranous type expression vector and transfection positive cell | |
| EA017398B1 (en) | Method for generating stable cell lines expressing high levels of a protein of interest | |
| US20220243193A1 (en) | Cell lines for high level production of protein | |
| WO2022243320A1 (en) | Method for producing a biomolecule by a cell | |
| CN109517800B (en) | Reconstructed ST cell for reinforcing endogenous synthesis of cholesterol and construction method and application thereof | |
| CN116003624B (en) | SIRT1 fusion proteins and uses thereof | |
| AU2019450349B2 (en) | Cell lines for high level production of protein-based pharmaceuticals | |
| CN115947861B (en) | Efficient hybridoma fusion method | |
| CN115850517B (en) | Method for improving GLP-1 Fc fusion protein yield | |
| US20240167006A1 (en) | High production of recombinant protein by making cell hybrids and enriching for a preferred mitochondrial phenotype | |
| US20240254470A1 (en) | Protein producer cells made by fusing cells together and selecting for high level expression of a transgene | |
| WO2024193739A1 (en) | Method for producing proteins in host cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120613 Termination date: 20141104 |
|
| EXPY | Termination of patent right or utility model |